Aradigm Corporation Share Price Nasdaq
Equities
US0385054004
Biotechnology & Medical Research
Sales 2016 | 195K 15.61M | Sales 2017 | 14.46M 1.16B | Capitalization | 97.3M 7.79B |
---|---|---|---|---|---|
Net income 2016 | -32M -2.56B | Net income 2017 | -10M -801M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M 750M | Net Debt 2017 | 7.91M 633M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |